Compound Sodium Ferulate Aspirin Capsules

It has strong anti-platelet aggregation effect and strong anti-experimental thrombosis effect, and has no obvious side effects on the cardiovascular system, respiratory system, and nervous system. No toxic reactions were found in long-term toxicity tests. The oral LD50 of mice is 1.9g/kg body weight, and the intraperitoneal injection LD50 of mice is 1.03g/kg body weight.

This product contains sodium ferulate (C10H9NaO4), aspirin (C9H8O4) and cinnarizine (C26H28N2), which should be 90.0% to 110.0% of the labeled amount.

This product is a capsule, and the contents are green, red, yellow, and white round micro-pellets.

It is suitable for preventing and treating ischemic cerebrovascular diseases, such as transient ischemic attack, ischemic stroke and cerebral arteriosclerosis.

Oral administration: Usual dosage: 1 tablet at a time, 3 times a day. Take it continuously for one month as a course of treatment. You can continue to take the next course of treatment after stopping the medication for one week. Do not increase the dosage at will.

No obvious toxic or side effects were observed.

It is contraindicated for those who are allergic to this product.

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.

Drug interactions may occur if used with other drugs. Please consult your doctor or pharmacist for details.

Keep away from light, sealed and stored in a dry place.

10s*2 boards

18 months

Livzon Pharmaceutical Grouping Limin Pharmaceutical FACTORY

• Founded in:

  1997-05-24

• Address:

  No. 89, Gongye West Road, Shaoguan City, Guangdong

• Tax NO.:

  91440200618357941C

• Registered Funds:

  61.56101 million yuan

• Email:

  Log in to view